PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Endocrinology and Diabetology Unit, Humanitas Clinical and Research Center, IRCCS, Milan, Italy marco.mirani@humanitas.it.\', \'Endocrinology and Diabetology Unit, Humanitas Clinical and Research Center, IRCCS, Milan, Italy.\', \'Biostatistics Unit, Humanitas Clinical and Research Center, IRCCS, Milan, Italy.\', \'Department of Biomedical Sciences, Humanitas University, Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2337/dc20-1340
?:hasPublicationType
?:journal
  • Diabetes care
is ?:pmid of
?:pmid
?:pmid
  • 33023989
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.693
?:rankingScore_hIndex
  • 319
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33023989>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33023989>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all